Physician profile
David Long-I Lin
NPI 1306936752
$11,542.79
in general payments reported to CMS, 2019-2025
31 companies · $3,695 in 2025
The $3,695 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,043 · 2020: $1,029 · 2021: $3,873 · 2022: $673 · 2023: $594 · 2024: $637 · 2025: $3,695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,200 · Food and Beverage: $2,098 · Travel and Lodging: $582 · Education: $46.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,200.00 |
| Food and Beverage | $2,097.76 |
| Travel and Lodging | $581.58 |
| Education | $46.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,647.22 | 2019-2025 | Ensite, Tacticath Ablation Catheter, Sensor Enabled, Eterna |
| Stryker Corporation | $2,498.07 | 2019-2025 | Mako, Insignia, Reunion |
| Smith+Nephew, INC. | $1,861.69 | 2019-2024 | Real Intelligence, K-15 Pork, Journey II |
| Orthofix Medical, INC. | $1,551.12 | 2021 | |
| Zimmer Biomet Holdings, INC. | $940.48 | 2019-2025 | Oxford, Gel-One Cross-Linked Hyaluronate |
| Horizon Therapeutics Plc | $278.65 | 2019-2022 | |
| Radius Health, INC. | $266.08 | 2019-2024 | Tymlos |
| Bioventus LLC | $251.00 | 2020-2025 | Supartz Fx Sodium Hyaluronate, Xcell, Exogen Ultrasound Bone Healing System |
| Heron Therapeutics, INC. | $223.86 | 2021-2025 | Zynrelef |
| Next Science LLC | $145.57 | 2025 | Xperience, Blastx |
| Miach Orthopaedics, INC. | $134.62 | 2022 | |
| Depuy Synthes Sales INC. | $79.49 | 2019-2023 | Orthovisc, Monovisc |
| Medinc of Texas | $76.85 | 2022-2025 | |
| Nalu Medical, INC. | $66.28 | 2025 | Nalu Neurostimulation System |
| Ermi LLC | $59.81 | 2020-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Orthoscience | $51.58 | 2021 | |
| Ethicon US, LLC | $50.43 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $46.72 | 2024-2025 | |
| Vericel Corporation | $45.43 | 2020-2023 | Maci |
| Acell, INC. | $36.17 | 2020 | |
| Carbofix Orthopedics INC | $33.83 | 2025 | |
| Becton, Dickinson and Company | $32.42 | 2023 | Channel Drain |
| Innovation Technologies INC | $31.20 | 2022 | |
| Pacira Therapeutics, INC. | $29.51 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $24.30 | 2022 | |
| Amgen INC. | $18.57 | 2022 | |
| Biocomposites INC | $17.75 | 2025 | Stimulan |
| Davol INC. | $12.76 | 2020 | |
| Intellijoint Surgical INC. | $12.50 | 2020 | |
| Assertio Therapeutics, INC. | $11.87 | 2019 | |
| Electronic Waveform Lab, INC. | $6.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.